.erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
sections
. published on: may 17, 2018 | last updated: may 17, 2018 5:42 pm pdt